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Introduction
Recently it has been reported that HCV-related cirrhotic
patients with persistently high serum levels of alanine
aminotransferase (ALT) activity have higher risk of devel-
opment of hepatocellular carcinoma (HCC) than those
with persistently low levels of ALT activity [1]. Vitamin A
has been demonstrated to have many biological functions
in regulation of growth and differentiation of normal and
cancer cells. Hepatic stellate cells (SCs) are the main stor-
age site of vitamin A and regulate homeostasis of vitamin
A. To analyze cellular and molecular mechanism in the
relationship between persistent high serum level of ALT
and HCC development from the viewpoint of vitamin A
handling, this study was performed.
Methods
Liver biopsy specimens obtained from 61 patients with
chronic hepatitis C, demonstrated to have antibody to
HCV by ELISA method, were investigated light and elec-
tron microscopically. They were subdivided into 4 groups
according to their serum ALT levels. Group A was com-
prised of 21 patients whose serum ALT levels were persist-
ently normal (≤40 IU/l) for at least one year: 6 men and
15 women, 29 to 64 years old. Group B was comprised of
23 patients whose serum ALT levels varied from ≥80 IU/l
to ≤40 IU/l : 14 men and 9 women, 27 to 69 years old.
Group C was comprised of 9 patients whose serum ALT
levels varied from ≥80 IU/l to <80 IU/l – >40 IU/l : 8 men
and one woman, 32 to 65 years old. Group D was com-
prised of 8 patients whose serum ALT levels were persist-
ently high (≥80 IU/l) for at least one year : 6 men and 2
women, 29 to 63 years old.
One micrometer-thin sections from tissues for electron
microscopy were stained with methylene blue and viewed
to count periportal vitamin A-rich or -poor SCs/mm2. The
periportal area (Figure 1) roughly corresponds to acinar
zone 1 proposed by Lamers and his colleagues [2].
Ultrathin sections were stained with uranyl acetate and
lead citrate and examined with an electron microscope
(JEM-100CX). Vitamin A-rich SCs were defined as the SCs
containing more than 10 vitamin A droplets whose diam-
eters are more than one micrometer (Figure 2). Cells
showing morphological features of fibroblasts or
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Lamers' model of acinar zonation Figure 1
Lamers' model of acinar zonation. "The periportal area" roughly corresponds to acinar zone 1.
Periportal vitamin A-rich stellate cell which contains a number of lipid droplets and has indented nucleus Figure 2
Periportal vitamin A-rich stellate cell which contains a number of lipid droplets and has indented nucleus. Bar = 5 micrometers.
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fibrocytes with few or no vitamin A droplets were not
added to total SCs.
All results were given as the mean ± standard deviation,
and the Student's t-test was used for statistical analysis.
Results
The number of periportal vitamin A-rich SCs was signifi-
cantly smaller in group D with persistently high serum
levels of ALT than those with persistently low serum levels
of ALT (p < 0.05) (Table 1). The total number of periportal
vitamin A-rich or -poor SCs was smaller in group D than
in group A (p < 0.01) or group B (p < 0.05).
Portal fibrosis in group D is attributed to the increase in
SCs if we include myofibroblasts or fibroblasts with few or
no vitamin A droplets. However, a decrease in periportal
SC was observed in this study because myofibroblast-like
cells or fibroblasts with fewer vitamin A droplets were not
added to total SCs.
Discussion
Many studies suggest that persistent inflammation may be
involved in development of carcinoma including HCC.
Tarao, et al. [3] analyzed 28 patients with HCV-related cir-
rhosis who had persistently high ALT levels (≥80 IU/l) and
28 patients who had persistently low ALT levels (<80 IU/
l), and revealed that 20 patients in the high ALT group
developed HCC during an average observation period of
7.0 ± 0.5 years. Of the 28 patients in the low ALT group,
only 7 patients developed HCC during an average obser-
vation period of 8.7 ± 0.6 years. They also reported a close
correlation between multicentric hepatocarcinogenesis
and sustained necroinflammation of the liver in patients
with hepatitis C virus-associated cirrhosis, and suggested
a strong correlation between the development of HCC
and liver cell necrosis.
Our present study shows that the number of periportal
vitamin A-rich SCs and vitamin A-poor SCs is significantly
smaller in CH patients with persistently high serum levels
of ALT (group D) than those with persistently low serum
levels of ALT (group A). SCs in the patients with fluctua-
tion of ALT levels (groups B and C), indicating that the
inflammation was not persistently active, had no signifi-
cant decrease in these numbers. This result also supports
that vitamin A content in SCs decreases only when the
necroinflammation is persistently active. This is the first
report demonstrating that there is an explicit relationship
between persistent active necroinflammation in the liver
and depletion of vitamin A in SCs.
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Table 1: Periportal Stellate Cells (SCs) in Subjects with Chronic Hepatitis C with fluctuation of Serum ALT Level
Group N Age (years) The number of periportal vitamin A-rich SCs 
(/mm2)
The total number of periportal vitamin A-rich and -poor SCs 
(/mm2)
A 21 48.1 ± 11.4 13.3 ± 8.3 63.0 ± 24.2
B 23 47.6 ± 13.1 15.0 ± 15.3 57.0 ± 25.5
C 9 49.8 ± 12.1 14.2 ± 12.1 55.0 ± 30.9
D 8 49.1 ± 12.3 5.3 ± 9.5 a 34.1 ± 17.4 aa,b
Significant difference compared with group A: a) p < 0.05, aa) p < 0.01 Significant difference compared with group B: b) p < 0.05 No significant 
difference compared with group C